SCHEMBL902680

SCHEMBL902680

C[Si](C)(C)CNC(=O)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.61
LMNA P02545 1/20 0.55
POLB P06746 1/20 0.55
HPGD P15428 3/20 0.51
ALDH1A1 P00352 1/20 0.51
NAAA Q02083 1/20 0.51
NPC1 O15118 4/20 0.50
RAB9A P51151 4/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
PRSS1 P07477 2/20 0.49
CTSG P08311 2/20 0.49
CTRB1 P17538 2/20 0.49
CMA1 P23946 2/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
KMT2A Q03164 1/20 0.49
EPHX2 P34913 1/20 0.49
MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12630364 0.83 GAA (0.55) GAALMNAPOLBHPGDALDH1A1
SCHEMBL9997413 0.82 CYP1A2 (0.57) GAAALDH1A1NAAANPC1RAB9A
SCHEMBL31138105 0.82 GAA (0.53) GAALMNAPOLBHPGDALDH1A1
SCHEMBL11360214 0.80 GAA (0.61) GAALMNAPOLBHPGDALDH1A1
SCHEMBL28003685 0.79 EPHX2 (0.55) HPGDNPC1RAB9ASMN1; SMN2HDAC1
SCHEMBL14822807 0.79 ALDH1A1 (0.40) GAALMNAPOLBALDH1A1NPC1
SCHEMBL22373763 0.79 NAAA (0.65) GAALMNAPOLBHPGDALDH1A1
SCHEMBL28003368 0.79 HPGD (0.57) GAALMNAHPGDALDH1A1NPC1
SCHEMBL21309871 0.78 EPHX2 (0.54) LMNAPOLBHPGDALDH1A1SMN1; SMN2
SCHEMBL28003687 0.78 CES2 (0.44) NPC1RAB9ASMN1; SMN2HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127728-A1 MODIFIED GRAPHENE, METHOD OF PRODUCING MODIFIED GRAPHENE, MODIFIED GRAPHENE-RESIN COMPOSITE, MODIFIED GRAPHENE SHEET, AND MODIFIED GRAPHENE DISPERSION CANON KK (JP) 2023-04-27 US disclosed
US-11518889-B2 Modified graphene, method of producing modified graphene, modified graphene-resin composite, modified graphene sheet, and modified graphene dispersion CANON KABUSHIKI KAISHA (JP) 2022-12-06 US disclosed
US-20200270463-A1 MODIFIED GRAPHENE, METHOD OF PRODUCING MODIFIED GRAPHENE, MODIFIED GRAPHENE-RESIN COMPOSITE, MODIFIED GRAPHENE SHEET, AND MODIFIED GRAPHENE DISPERSION CANON KABUSHIKI KAISHA (JP) 2020-08-27 US disclosed
EP-2621900-A1 IMINE SUBSTITUTED 2, 4 - DIARYL - PYRROLINE DERIVATIVES AS PESTICIDES BASF SE (DE) 2013-08-07 EP disclosed
CN-101939295-B Insecticidal arylpyrrolines BAYER CROPSCIENCE AG 2013-04-24 CN disclosed
WO-2012042007-A1 IMINE SUBSTITUTED 2, 4 - DIARYL - PYRROLINE DERIVATIVES AS PESTICIDES BASF SE (DE) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200270463-A1 MODIFIED GRAPHENE, METHOD OF PRODUCING MODIFIED GRAPHENE, MODIFIED GRAPHENE-RESIN COMPOSITE, MODIFIED GRAPHENE SHEET, AND MODIFIED GRAPHENE DISPERSION GRIA1, GRIN1, NR3C1 GAA 2467/4885LMNA 1145/4885POLB 2254/4885
US-20230127728-A1 MODIFIED GRAPHENE, METHOD OF PRODUCING MODIFIED GRAPHENE, MODIFIED GRAPHENE-RESIN COMPOSITE, MODIFIED GRAPHENE SHEET, AND MODIFIED GRAPHENE DISPERSION GRIA1, GRIN1, NR3C1 GAA 2473/4885LMNA 1129/4885POLB 2219/4885
US-11518889-B2 Modified graphene, method of producing modified graphene, modified graphene-resin composite, modified graphene sheet, and modified graphene dispersion GRIA1, GRIN1, NR3C1 GAA 2467/4885LMNA 1145/4885POLB 2254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.